Papers
2
Total Citations
50
H-Index
2
About
Riu Hamada is a prominent urologic surgeon and researcher whose work centers on improving surgical outcomes for prostate cancer patients, with a particular focus on robot-assisted radical prostatectomy (RARP) and biochemical recurrence prediction. Hamada's most impactful contribution is the investigation of double-layered posterior rhabdosphincter reconstruction (PR) during RARP, a technique aimed at accelerating the early recovery of urinary continence. Their seminal 2012 paper, with 29 citations, critically examined the Rocco original double-layered PR, providing evidence that this surgical refinement can significantly enhance patients' quality of life post-surgery—a major concern for men undergoing prostatectomy. Beyond surgical technique, Hamada has advanced risk stratification for high-risk prostate cancer. Their 2015 study, cited 21 times, identified preoperative predictive factors for biochemical recurrence, enabling more personalized prognosis and treatment planning. By combining innovative surgical methods with robust predictive modeling, Hamada has helped bridge the gap between operative precision and long-term oncologic control. Their work continues to influence clinical guidelines and offers tangible hope for faster recovery and better outcomes in prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2